|
InfoMedics Brand Accelerator Program Provided Patient Feedback on
Medication for Chronic Eye Condition
InfoMedics implemented a physician-oriented, patient-centered Patient Experience Program to gather data on clinically relevant outcomes associated with treatments for a chronic eye condition. Prescribing physicians received feedback about their patients’ responses to treatment, allowing them to see first-hand, from their own patients, the medication’s effectiveness.
Full Case Study >
InfoMedics Treatment Educator Promote Compliance with Cholesterol Medication
InfoMedics implemented an Educational Patient Experience Program to educate patients about the medication and the importance of treatment compliance in successfully improving cholesterol levels. Program allowed patients to receive important educational information about the potential side-effects and the importance of compliance, and this information was provided prior to the patient filling the first prescription.
Full Case Study >
Adherence Driver Educated Patients about Dyslipidemia, delivering
Improved Adherence and NRx
InfoMedics designed a program to support physicians in their efforts to educate patients about dyslipidemia and the importance of control and adherence. Physicians encouraged patients to enroll and patients received tailored education and support, based upon survey-driven segmentation. The program generated improvements in adherence of between 17% and 26%, while increasing new prescriptions for the brand by 11%.
Full Case Study >
InfoMedics Campaign Booster Supported Large Pharmaceutical Company with
New Indication for Neurology – Anxiety
InfoMedics' approach included three phases. Phase I, a series of national CME teleconferences, was designed to engage physicians in discussion about the condition and medication, as well as enroll interested physicians into Phase II, the patient registry. In Phase II, the enrolled physicians used validated screening tools to assess their patient populations. Patients identified as screening positive were instructed to call a toll-free number and answer a series of symptom-related questions. A summary of each patient's responses was sent to the prescribing physician. Phase III was implemented to augment the release of the client's DTC campaign for their anxiety disorder medication.
Full Case Study >
|
